Life Science Company
Merck has acquired 26 companies, including 13 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 5 assets.
Merck’s largest acquisition to date was in 2009, when it acquired Schering-Plough for $41.1B. It’s largest disclosed sale occurred in 2009, when it sold Merial to Sanofi SA for $4.0B. Merck has acquired in 9 different US states, and 7 countries. The Company’s most targeted sectors include life science (93%) and information technology (4%).
Join Mergr and gain access to Merck’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity31
- M&A Buy Activity26
- M&A Sell Activity5
- Total Sectors Invested 3
- Total Countries Invested 7
- M&A Buy/Sell Connections 12
- M&A Advisors 10
Unlimited Searches
